Patent details
EP3687562 Title: TREATMENT OF RECURRENT IDIOPATHIC PERICARDITIS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN
Basic Information
- Publication number:
- EP3687562
- PCT Application Number:
- US2018052985
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP187865878
- PCT Publication Number:
- WO2019067639
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OF RECURRENT IDIOPATHIC PERICARDITIS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN
- French Title of Invention:
- TRAITEMENT DE LA PÉRICARDITE RÉCURRENTE IDIOPATHIQUE PAR ADMINISTRATION D'UNE PROTÉINE DE FUSION ANTAGONISTE DU RÉCEPTEUR D'INTERLEUKINE-1
- German Title of Invention:
- BEHANDLUNG VON IDIOPATHISCHER REKURRIERENDEN PERIKARDITIS DURCH VERABREICHUNG VON INTERLEUKIN-1-REZEPTOR-ANTAGONIST-FUSIONSPROTEIN
- SPC Number:
Dates
- Filing date:
- 26/09/2018
- Grant date:
- 19/03/2025
- EP Publication Date:
- 05/08/2020
- PCT Publication Date:
- 04/04/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/03/2025
- EP B1 Publication Date:
- 19/03/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 26/09/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/03/2025
- Name:
- Regeneron Pharmaceuticals, Inc.
- Address:
- 777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)
Agent
- Name:
- HERNANDEZ IP
- From:
- 21/03/2025
- Address:
- Ludwig-Ganghofer-Str. 42, 82031, Grünwald, Germany (DE)
- To:
Inventor
1
- Name:
- PAOLINI, John
- Address:
- United States (US)
2
- Name:
- TESSARI, Eben
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201762563387 P
- Priority Date:
- 26/09/2017
- Priority Country:
- United States (US)
2
- Priority Number:
- 201862616819 P
- Priority Date:
- 12/01/2018
- Priority Country:
- United States (US)
3
- Priority Number:
- 201862625075 P
- Priority Date:
- 01/02/2018
- Priority Country:
- United States (US)
4
- Priority Number:
- 201862639425 P
- Priority Date:
- 06/03/2018
- Priority Country:
- United States (US)
5
- Priority Number:
- 201862654291 P
- Priority Date:
- 06/04/2018
- Priority Country:
- United States (US)
6
- Priority Number:
- 201862691552 P
- Priority Date:
- 28/06/2018
- Priority Country:
- United States (US)
7
- Priority Number:
- 201862716331 P
- Priority Date:
- 08/08/2018
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 38/17; A61K 39/395; A61K 47/68; A61P 9/00; A61P 29/00; A61K 38/20;
Publication
European Patent Bulletin
- Issue number:
- 202512
- Publication date:
- 19/03/2025
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 30/09/2026
- Annual Fee Number:
- 9
- Annual Fee Amount:
- 115 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 12/09/2025
- Last Annual Fee Paid Number:
- 8
- Last Annual Fee Paid Amount:
- 99 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 21/03/2025 | Power Of Attorney | 1 |
| 21/03/2025 | Outgoing Correspondence | 1 |